1049821

Hikma Pharmaceuticals USA INC — FEI 1510690

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 18, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Columbus, OH (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
150521 CFR 211.122(d)Label storage access limited to authorized personnel